• Home>
  • Stocks>
  • Caplin Point Laboratories Ltd Share Price
Caplin Point Laboratories Ltd share price logo

Caplin Point Laboratories Ltd Share Price (CAPLIPOINT)

Check the latest share price of Caplin Point Laboratories Ltd, along with the price target, peer comparison, quarterly results, recent news, expert analysis, shareholding pattern, and other key fundamentals to make informed investment decisions.

₹2140.31.27%

as on 04:01PM, 13 Jun 2025

NSE

bell
The current prices are delayed by 15 mins, login to check live prices.

Caplin Point Laboratories Ltd Stock Performance

Get live Caplin Point Laboratories Ltd share price, day's high and low, historical returns, and market stats.

  • Day's Low

    Day's High

    ₹2,056
    Day's Price Range
    ₹2,149
  • 52 Week's Low

    52 Week's High

    ₹1,365
    52-Week Price Range
    ₹2,641
1 Month Return+ 6.2 %
3 Month Return+ 15.74 %
1 Year Return+ 54.88 %
3 Year Return+ 198.95 %
5 Year Return+ 432.28 %
Previous Close₹2,113.40
Open₹2,080.00
Volume1.13L
Upper Circuit₹2,536.00
Lower Circuit₹1,690.80

Caplin Point Laboratories Ltd Fundamentals & Key Indicators

Check Caplin Point Laboratories Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

₹16,268.78 Cr

Return on Equity (ROE)

22.43

PE Ratio (TTM)

30.33

Return on capital employed (ROCE)

28.84

Industry PE ratio

57.39

Beta (LTM)

1.5

P/B Ratio

7.2

Dividend Yield

0.38

PEG Ratio

2.92

Quarterly Earnings Growth YOY

19.84

EPS (TTM)

60.75

Sector

Pharmaceuticals

Book Value

276.38

Technical Analysis

How to invest in Caplin Point Laboratories Ltd?

Investing in Caplin Point Laboratories Ltd is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Caplin Point Laboratories Ltd or CAPLIPOINT on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

For example: You can buy 10 shares of Caplin Point Laboratories Ltd or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Caplin Point Laboratories Ltd with just a few clicks!

Caplin Point Laboratories Ltd Stock's Interest Amongst Investors

29.39%

Period Jun 14, 2025 to May 15, 2025. Change in 30 Days vs previous period

Investment in Caplin Point Laboratories Ltd Shares on INDmoney has grown by 29.39% over the past 30 days, indicating increased transactional activity.

-1%

Period Jun 14, 2025 to May 15, 2025. Change in 30 Days vs previous period

Search interest for Caplin Point Laboratories Ltd Stock has decreased by -1% in the last 30 days, reflecting a downward trend in search activity.

Caplin Point Laboratories Ltd Valuation

Track how Caplin Point Laboratories Ltd P/E has moved over time to understand its valuation trends.

Caplin Point Laboratories Ltd in the last 5 years

  • Overview

  • Trends

Lowest (6.76x)

March 24, 2020

Today (30.33x)

June 13, 2025

Industry (57.39x)

June 13, 2025

Highest (40.01x)

December 27, 2024

LowHigh

Today’s Price to Earnings Ratio: 30.33x

Caplin Point Laboratories Ltd Stock Recommendation

Get updated buy, sell, and hold recommendations by analysts on Caplin Point Laboratories Ltd.

based on 3 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

100% of analysts recommend a 'BUY' rating for Caplin Point Laboratories Ltd. Average target price of ₹2472

Source: S&P Global Market Intelligence

Caplin Point Laboratories Ltd Share Price Target

Get share price movements and forecasts by analysts on Caplin Point Laboratories Ltd.

Caplin Point Laboratories Ltd price forecast by 3 analysts

Upside of15.50%

High

₹2516

Target

₹2472.00

Low

₹2400

Caplin Point Laboratories Ltd target price ₹2472, a slight upside of 15.5% compared to current price of ₹2140.3. According to 3 analysts rating.

Source: S&P Global Market Intelligence

Caplin Point Laboratories Ltd Financial Results

Get the annual and quarterly financial summary of Caplin Point Laboratories Ltd, including revenue, profit, loss and more.

Value in ₹ crore
DetailsQ4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25
Revenue

(in ₹ Cr)

453 (0%)459 (1%)483 (5%)493 (2%)502 (2%)
Net Income

(in ₹ Cr)

121 (0%)125 (3%)131 (5%)140 (7%)145 (4%)
Net Profit Margin26.75% (0%)27.22% (2%)27.08% (1%)28.41% (5%)28.91% (2%)
Value in ₹ crore
DetailsFY21FY22FY23FY24
Total Assets

(in ₹ Cr)

861 (0%)1054 (22%)1303 (24%)1522 (17%)
Total Liabilities

(in ₹ Cr)

102 (0%)124 (21%)163 (32%)132 (19%)
Value in ₹ crore
DetailsFY20FY21FY22FY23FY24
Operating Cash Flow

(in ₹ Cr)

87 (0%)295 (239%)231 (22%)157 (32%)111 (29%)

Indices Featuring Caplin Point Laboratories Ltd Stock

Check stock indices that include Caplin Point Laboratories Ltd.

Nifty Smallcap 250

₹17,210.40

-0.38 (-66.5%)

Nifty 500

₹22,906.20

-0.61 (-140.25%)

Nifty MidSmallcap 400

₹19,931.15

-0.37 (-73.35%)

S&P BSE 250 SmallCap

₹6,870.18

-0.37 (-25.22%)

S&P BSE 400 MidSmallCap

₹12,015.06

-0.31 (-37.67%)

BSE Small-Cap

₹53,370.29

-0.3 (-161.18%)

BSE Healthcare

₹43,995.31

0.08 (34.42%)

BSE 500

₹35,946.69

-0.57 (-206.81%)

Caplin Point Laboratories Ltd Earnings and Dividends

View detailed summary of the earnings and dividend history of Caplin Point Laboratories Ltd.

  • Caplin Point Laboratories Ltd Earnings Results

    Caplin Point Laboratories Ltd’s net profit jumped 17.25% since last year same period to ₹142.57Cr in the Q4 2024-2025. On a quarterly growth basis, Caplin Point Laboratories Ltd has generated 2.6% jump in its net profits since last 3-months.

    Read More about Earnings Results
  • Caplin Point Laboratories Ltd Dividends May,2025

    In the quarter ending March 2025, Caplin Point Laboratories Ltd has declared dividend of ₹3 - translating a dividend yield of 0.37%.

    Read More about Dividends

Caplin Point Laboratories Ltd Shareholding Pattern

View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Caplin Point Laboratories Ltd.

InvestorsHoldings %Quarterly Trend3M change
Promoter Holdings
70.56%
0.00
Foreign Institutions
5.7%
0.00
Mutual Funds
1.74%
0.00
Retail Investors
21.7%
0.00
Others
0.29%
0.00

Caplin Point Laboratories Ltd vs Peers

Compare market cap, revenue, PE, and other key metrics of Caplin Point Laboratories Ltd with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
BUY16,268.7886.46%0.504611,694
BUY38,428.87101.79%0.523001,051
BUY17,430.6117.42%0.57726,702
NA5,383.812.8%0.79-38875
BUY14,436.5943.15%0.682441,515

Caplin Point Laboratories Ltd News & Key Events

Latest news and events in one place to help you make informed investing decisions in Caplin Point Laboratories Ltd.

  • Caplin Point Acquires Mexican Pharma Firm Triwin - 04 Jun, 2025

    Caplin Point Laboratories, through its subsidiary, has signed a Share Purchase Agreement to acquire Triwin Pharma S.A DE C.V, enhancing its presence in the Mexican pharmaceutical market. This strategic move aims to facilitate government tenders and establish a stock-and-sale model in Latin America.
  • Caplin Point Signals Bullish Trend with Breakout - 20 May, 2025

    Caplin Point Laboratories has broken above the ₹2,100 level, indicating the end of consolidation and a bullish trend. With strong volumes and an RSI of 71, the stock shows potential for further upside, targeting ₹2,600 while maintaining a stop loss at ₹2,000.
  • Caplin Point Laboratories Reports Strong Q4 Earnings - 15 May, 2025

    Caplin Point Laboratories reported a 17.25% increase in consolidated net profit for Q4 March 2025, reaching Rs 142.57 crore. Sales rose 10.86% to Rs 502.45 crore. For the full year, net profit increased by 17.33% to Rs 536.31 crore, with sales up 14.37% to Rs 1937.47 crore.
  • Caplin Point Subsidiary Gains USFDA Approval - 14 May, 2025

    Caplin Point Laboratories' subsidiary, Caplin Steriles, has received USFDA approval for Haloperidol Decanoate Injection, a generic treatment for schizophrenia, potentially entering a $16.4 million market.

Insights on Caplin Point Laboratories Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 19 quarters, 269.88 Cr → 528.27 Cr (in ₹), with an average increase of 3.7% per quarter

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 4.86% to 5.70% in Mar 2025 quarter

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, CAPLIPOINT has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, CAPLIPOINT stock has moved up by 4.4%

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, CAPLIPOINT has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 14 quarters, 74.95 Cr → 142.57 Cr (in ₹), with an average increase of 4.8% per quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 70.56% of holdings in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 1.86% to 1.74% in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 22.47% to 21.70% in Mar 2025 quarter

About Caplin Point Laboratories Ltd

Caplin Point Laboratories Limited was founded in the year 1990 and is a fully integrated transnational pharmaceutical company. With over 4000 product registrations covering 36 therapeutic segments, the company has set up its presence in 23 countries. It specializes in producing and marketing of wide range of generic formulations and branded products and exporting them to markets like the US, European Union, Africa, LATAM and others. The company has also established a trading branch in Nairobi Kenya and a warehouse in Miami USA in collaboration with Lockett Corp. It completed splitting its shares in 2016 from Rs. 10 to Rs. 2 each. As on date, the company has three subsidiaries in India, Hong Kong and Colombia. It invested in Argus Salud Pharma LLP and set up a Joint venture in China. It also ventured into the ecommerce space. In the year 2021, the company has already received four ANDA approvals and 8 product launches. It has planned to file more 18 ANDAs with an addressable market size of USD 1.95 billion and is investing a sum of Rs. 140 crores in setting up its second Injectable Plant with 2 Vial lines, a Lyophilizer line and a Pre filled syringe line.

Revenue: ₹502.45Cr as on March 2025 (Q4 FY25)
Net Profit: ₹145.28Cr as on March 2025 (Q4 FY25)
Listing date: 23 Jun, 2014
Chairperson Name: C C Paarthipan
OrganisationCaplin Point Laboratories Ltd
HeadquartersChennai
IndustryPharmaceuticals
CEOC C Paarthipan
E-voting on sharesClick here to vote

Mutual Funds that own Caplin Point Laboratories Ltd

Check out the Mutual Funds with significant holdings in Caplin Point Laboratories Ltd.

FAQs

What is Caplin Point Laboratories Ltd share price today?

Caplin Point Laboratories Ltd share price today stands at ₹2140.3, Open: ₹2080, Previous Close: ₹2113.4, High: ₹2149, Low: ₹2056, 52 Week High: ₹2641, 52 Week Low: ₹1365.

What is today's traded volume of Caplin Point Laboratories Ltd?

Today's traded volume of Caplin Point Laboratories Ltd is 1.13L. Which means that 1.13L shares of Caplin Point Laboratories Ltd were bought and sold on the stock market during today's trading session.

What is Caplin Point Laboratories Ltd's market cap today?

Today's market capitalisation of Caplin Point Laboratories Ltd is ₹16,268.78 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.

What is the 52 week high and 52 week low range of Caplin Point Laboratories Ltd?

Caplin Point Laboratories Ltd’s 52 week high is ₹2641 and 52 week low is ₹1365. The current share price of Caplin Point Laboratories Ltd is ₹2140.3, which is -18.96% down from its 52 week high and 56.80% up from its 52 week low.